 | • レポートコード：QFJ1-4655 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、副鼻腔がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線療法、化学療法）、用途別市場規模（病院・クリニック、がん治療研究センター、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・副鼻腔がん治療の市場動向 ・企業の競争状況、市場シェア ・副鼻腔がん治療の種類別市場規模と予測2016-2027（手術、放射線療法、化学療法） ・副鼻腔がん治療の用途別市場規模と予測2016-2027（病院・クリニック、がん治療研究センター、研究所、その他） ・副鼻腔がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・副鼻腔がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・副鼻腔がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・副鼻腔がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・副鼻腔がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie, Inc.、Pfizer Inc.、Eli Lilly and Company、Bristol-Myers Squibb Company、Roche、Becton Dickinson、Novartis AG、Ipsen Biopharmaceuticals Inc.、Thermo Fisher Scientific、Abbott、GE Healthcare、Agilent Technologies Inc.、AstraZeneca、Boehringer Ingelheim、Bayer） ・結論 |
If cancer is in the ethmoid sinus, treatment may include the following: Surgery followed by radiation therapy. A clinical trial of combination chemotherapy before surgery or radiation therapy. A clinical trial of combination chemotherapy after surgery or other cancer treatment.
Market Analysis and Insights: Global Paranasal Sinus Cancer Treatment Market
The global Paranasal Sinus Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Paranasal Sinus Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Paranasal Sinus Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Paranasal Sinus Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Paranasal Sinus Cancer Treatment market.
Global Paranasal Sinus Cancer Treatment Scope and Market Size
Paranasal Sinus Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Paranasal Sinus Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast and in terms of revenue and forecast for the period 2016-2027.
Segment
Surgery
Radiotherapy
Chemotherapy
Segment
Hospital and Clinics
Cancer Treatment and Research Center
Research Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie, Inc.
Pfizer Inc.
Eli Lilly and Company
Bristol-Myers Squibb Company
Roche
Becton Dickinson
Novartis AG
Ipsen Biopharmaceuticals Inc.
Thermo Fisher Scientific
Abbott
GE Healthcare
Agilent Technologies Inc.
AstraZeneca
Boehringer Ingelheim
Bayer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paranasal Sinus Cancer Treatment Market Size Growth Rate : 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Radiotherapy
1.2.4 Chemotherapy
1.3 Market by Application
1.3.1 Global Paranasal Sinus Cancer Treatment Market Share : 2016 VS 2021 VS 2027
1.3.2 Hospital and Clinics
1.3.3 Cancer Treatment and Research Center
1.3.4 Research Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Paranasal Sinus Cancer Treatment Market Perspective (2016-2027)
2.2 Paranasal Sinus Cancer Treatment Growth Trends by Regions
2.2.1 Paranasal Sinus Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Paranasal Sinus Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Paranasal Sinus Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Paranasal Sinus Cancer Treatment Industry Dynamic
2.3.1 Paranasal Sinus Cancer Treatment Market Trends
2.3.2 Paranasal Sinus Cancer Treatment Market Drivers
2.3.3 Paranasal Sinus Cancer Treatment Market Challenges
2.3.4 Paranasal Sinus Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paranasal Sinus Cancer Treatment Players by Revenue
3.1.1 Global Top Paranasal Sinus Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Paranasal Sinus Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Paranasal Sinus Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Paranasal Sinus Cancer Treatment Revenue
3.4 Global Paranasal Sinus Cancer Treatment Market Concentration Ratio
3.4.1 Global Paranasal Sinus Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paranasal Sinus Cancer Treatment Revenue in 2020
3.5 Paranasal Sinus Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Paranasal Sinus Cancer Treatment Product Solution and Service
3.7 Date of Enter into Paranasal Sinus Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Paranasal Sinus Cancer Treatment Breakdown Data
4.1 Global Paranasal Sinus Cancer Treatment Historic Market Size (2016-2021)
4.2 Global Paranasal Sinus Cancer Treatment Forecasted Market Size (2022-2027)
5 Paranasal Sinus Cancer Treatment Breakdown Data
5.1 Global Paranasal Sinus Cancer Treatment Historic Market Size (2016-2021)
5.2 Global Paranasal Sinus Cancer Treatment Forecasted Market Size (2022-2027)
6 North America
6.1 North America Paranasal Sinus Cancer Treatment Market Size (2016-2027)
6.2 North America Paranasal Sinus Cancer Treatment Market Size
6.2.1 North America Paranasal Sinus Cancer Treatment Market Size (2016-2021)
6.2.2 North America Paranasal Sinus Cancer Treatment Market Size (2022-2027)
6.2.3 North America Paranasal Sinus Cancer Treatment Market Size (2016-2027)
6.3 North America Paranasal Sinus Cancer Treatment Market Size
6.3.1 North America Paranasal Sinus Cancer Treatment Market Size (2016-2021)
6.3.2 North America Paranasal Sinus Cancer Treatment Market Size (2022-2027)
6.3.3 North America Paranasal Sinus Cancer Treatment Market Size (2016-2027)
6.4 North America Paranasal Sinus Cancer Treatment Market Size by Country
6.4.1 North America Paranasal Sinus Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Paranasal Sinus Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Paranasal Sinus Cancer Treatment Market Size (2016-2027)
7.2 Europe Paranasal Sinus Cancer Treatment Market Size
7.2.1 Europe Paranasal Sinus Cancer Treatment Market Size (2016-2021)
7.2.2 Europe Paranasal Sinus Cancer Treatment Market Size (2022-2027)
7.2.3 Europe Paranasal Sinus Cancer Treatment Market Size (2016-2027)
7.3 Europe Paranasal Sinus Cancer Treatment Market Size
7.3.1 Europe Paranasal Sinus Cancer Treatment Market Size (2016-2021)
7.3.2 Europe Paranasal Sinus Cancer Treatment Market Size (2022-2027)
7.3.3 Europe Paranasal Sinus Cancer Treatment Market Size (2016-2027)
7.4 Europe Paranasal Sinus Cancer Treatment Market Size by Country
7.4.1 Europe Paranasal Sinus Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Paranasal Sinus Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size
8.2.1 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size (2016-2021)
8.2.2 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size (2022-2027)
8.2.3 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size (2016-2027)
8.3 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size
8.3.1 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size (2016-2021)
8.3.2 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size (2022-2027)
8.3.3 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size (2016-2027)
8.4 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Paranasal Sinus Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Paranasal Sinus Cancer Treatment Market Size (2016-2027)
9.2 Latin America Paranasal Sinus Cancer Treatment Market Size
9.2.1 Latin America Paranasal Sinus Cancer Treatment Market Size (2016-2021)
9.2.2 Latin America Paranasal Sinus Cancer Treatment Market Size (2022-2027)
9.2.3 Latin America Paranasal Sinus Cancer Treatment Market Size (2016-2027)
9.3 Latin America Paranasal Sinus Cancer Treatment Market Size
9.3.1 Latin America Paranasal Sinus Cancer Treatment Market Size (2016-2021)
9.3.2 Latin America Paranasal Sinus Cancer Treatment Market Size (2022-2027)
9.3.3 Latin America Paranasal Sinus Cancer Treatment Market Size (2016-2027)
9.4 Latin America Paranasal Sinus Cancer Treatment Market Size by Country
9.4.1 Latin America Paranasal Sinus Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Paranasal Sinus Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size
10.2.1 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size (2016-2021)
10.2.2 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size (2022-2027)
10.2.3 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size (2016-2027)
10.3 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size
10.3.1 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size (2016-2021)
10.3.2 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size (2022-2027)
10.3.3 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size (2016-2027)
10.4 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Paranasal Sinus Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie, Inc.
11.1.1 AbbVie, Inc. Company Details
11.1.2 AbbVie, Inc. Business Overview
11.1.3 AbbVie, Inc. Paranasal Sinus Cancer Treatment Introduction
11.1.4 AbbVie, Inc. Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.1.5 AbbVie, Inc. Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Paranasal Sinus Cancer Treatment Introduction
11.2.4 Pfizer Inc. Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.2.5 Pfizer Inc. Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Paranasal Sinus Cancer Treatment Introduction
11.3.4 Eli Lilly and Company Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Details
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Paranasal Sinus Cancer Treatment Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Paranasal Sinus Cancer Treatment Introduction
11.5.4 Roche Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Details
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson Paranasal Sinus Cancer Treatment Introduction
11.6.4 Becton Dickinson Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.6.5 Becton Dickinson Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Paranasal Sinus Cancer Treatment Introduction
11.7.4 Novartis AG Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 Ipsen Biopharmaceuticals Inc.
11.8.1 Ipsen Biopharmaceuticals Inc. Company Details
11.8.2 Ipsen Biopharmaceuticals Inc. Business Overview
11.8.3 Ipsen Biopharmaceuticals Inc. Paranasal Sinus Cancer Treatment Introduction
11.8.4 Ipsen Biopharmaceuticals Inc. Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.8.5 Ipsen Biopharmaceuticals Inc. Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Paranasal Sinus Cancer Treatment Introduction
11.9.4 Thermo Fisher Scientific Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Paranasal Sinus Cancer Treatment Introduction
11.10.4 Abbott Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.10.5 Abbott Recent Development
11.11 GE Healthcare
11.11.1 GE Healthcare Company Details
11.11.2 GE Healthcare Business Overview
11.11.3 GE Healthcare Paranasal Sinus Cancer Treatment Introduction
11.11.4 GE Healthcare Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.11.5 GE Healthcare Recent Development
11.12 Agilent Technologies Inc.
11.12.1 Agilent Technologies Inc. Company Details
11.12.2 Agilent Technologies Inc. Business Overview
11.12.3 Agilent Technologies Inc. Paranasal Sinus Cancer Treatment Introduction
11.12.4 Agilent Technologies Inc. Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.12.5 Agilent Technologies Inc. Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Paranasal Sinus Cancer Treatment Introduction
11.13.4 AstraZeneca Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.13.5 AstraZeneca Recent Development
11.14 Boehringer Ingelheim
11.14.1 Boehringer Ingelheim Company Details
11.14.2 Boehringer Ingelheim Business Overview
11.14.3 Boehringer Ingelheim Paranasal Sinus Cancer Treatment Introduction
11.14.4 Boehringer Ingelheim Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.14.5 Boehringer Ingelheim Recent Development
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer Paranasal Sinus Cancer Treatment Introduction
11.15.4 Bayer Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021)
11.15.5 Bayer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Paranasal Sinus Cancer Treatment Market Size Growth Rate (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Chemotherapy
Table 5. Global Paranasal Sinus Cancer Treatment Market Size Growth (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Paranasal Sinus Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Paranasal Sinus Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Paranasal Sinus Cancer Treatment Market Share by Regions (2016-2021)
Table 9. Global Paranasal Sinus Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Paranasal Sinus Cancer Treatment Market Share by Regions (2022-2027)
Table 11. Paranasal Sinus Cancer Treatment Market Trends
Table 12. Paranasal Sinus Cancer Treatment Market Drivers
Table 13. Paranasal Sinus Cancer Treatment Market Challenges
Table 14. Paranasal Sinus Cancer Treatment Market Restraints
Table 15. Global Paranasal Sinus Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Paranasal Sinus Cancer Treatment Market Share by Players (2016-2021)
Table 17. Global Top Paranasal Sinus Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paranasal Sinus Cancer Treatment as of 2020)
Table 18. Ranking of Global Top Paranasal Sinus Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Paranasal Sinus Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Paranasal Sinus Cancer Treatment Product Solution and Service
Table 22. Date of Enter into Paranasal Sinus Cancer Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Paranasal Sinus Cancer Treatment Market Size (2016-2021) (US$ Million)
Table 25. Global Paranasal Sinus Cancer Treatment Revenue Market Share (2016-2021)
Table 26. Global Paranasal Sinus Cancer Treatment Forecasted Market Size (2022-2027) (US$ Million)
Table 27. Global Paranasal Sinus Cancer Treatment Revenue Market Share (2022-2027) & (US$ Million)
Table 28. Global Paranasal Sinus Cancer Treatment Market Size Share (2016-2021) & (US$ Million)
Table 29. Global Paranasal Sinus Cancer Treatment Revenue Market Share (2016-2021)
Table 30. Global Paranasal Sinus Cancer Treatment Forecasted Market Size (2022-2027) (US$ Million)
Table 31. Global Paranasal Sinus Cancer Treatment Revenue Market Share (2022-2027) & (US$ Million)
Table 32. North America Paranasal Sinus Cancer Treatment Market Size (2016-2021) (US$ Million)
Table 33. North America Paranasal Sinus Cancer Treatment Market Size (2022-2027) & (US$ Million)
Table 34. North America Paranasal Sinus Cancer Treatment Market Size (2016-2021) (US$ Million)
Table 35. North America Paranasal Sinus Cancer Treatment Market Size (2022-2027) & (US$ Million)
Table 36. North America Paranasal Sinus Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Paranasal Sinus Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Paranasal Sinus Cancer Treatment Market Size (2016-2021) (US$ Million)
Table 39. Europe Paranasal Sinus Cancer Treatment Market Size (2022-2027) & (US$ Million)
Table 40. Europe Paranasal Sinus Cancer Treatment Market Size (2016-2021) (US$ Million)
Table 41. Europe Paranasal Sinus Cancer Treatment Market Size (2022-2027) & (US$ Million)
Table 42. Europe Paranasal Sinus Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Paranasal Sinus Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Paranasal Sinus Cancer Treatment Market Size (2016-2021) (US$ Million)
Table 45. Asia-Pacific Paranasal Sinus Cancer Treatment Market Size (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Paranasal Sinus Cancer Treatment Market Size (2016-2021) (US$ Million)
Table 47. Asia-Pacific Paranasal Sinus Cancer Treatment Market Size (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Paranasal Sinus Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Paranasal Sinus Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Paranasal Sinus Cancer Treatment Market Size (2016-2021) (US$ Million)
Table 51. Latin America Paranasal Sinus Cancer Treatment Market Size (2022-2027) & (US$ Million)
Table 52. Latin America Paranasal Sinus Cancer Treatment Market Size (2016-2021) (US$ Million)
Table 53. Latin America Paranasal Sinus Cancer Treatment Market Size (2022-2027) & (US$ Million)
Table 54. Latin America Paranasal Sinus Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Paranasal Sinus Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Paranasal Sinus Cancer Treatment Market Size (2016-2021) (US$ Million)
Table 57. Middle East & Africa Paranasal Sinus Cancer Treatment Market Size (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Paranasal Sinus Cancer Treatment Market Size (2016-2021) (US$ Million)
Table 59. Middle East & Africa Paranasal Sinus Cancer Treatment Market Size (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Paranasal Sinus Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Paranasal Sinus Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. AbbVie, Inc. Company Details
Table 63. AbbVie, Inc. Business Overview
Table 64. AbbVie, Inc. Paranasal Sinus Cancer Treatment Product
Table 65. AbbVie, Inc. Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 66. AbbVie, Inc. Recent Development
Table 67. Pfizer Inc. Company Details
Table 68. Pfizer Inc. Business Overview
Table 69. Pfizer Inc. Paranasal Sinus Cancer Treatment Product
Table 70. Pfizer Inc. Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 71. Pfizer Inc. Recent Development
Table 72. Eli Lilly and Company Company Details
Table 73. Eli Lilly and Company Business Overview
Table 74. Eli Lilly and Company Paranasal Sinus Cancer Treatment Product
Table 75. Eli Lilly and Company Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly and Company Recent Development
Table 77. Bristol-Myers Squibb Company Company Details
Table 78. Bristol-Myers Squibb Company Business Overview
Table 79. Bristol-Myers Squibb Company Paranasal Sinus Cancer Treatment Product
Table 80. Bristol-Myers Squibb Company Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Company Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Paranasal Sinus Cancer Treatment Product
Table 85. Roche Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 86. Roche Recent Development
Table 87. Becton Dickinson Company Details
Table 88. Becton Dickinson Business Overview
Table 89. Becton Dickinson Paranasal Sinus Cancer Treatment Product
Table 90. Becton Dickinson Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 91. Becton Dickinson Recent Development
Table 92. Novartis AG Company Details
Table 93. Novartis AG Business Overview
Table 94. Novartis AG Paranasal Sinus Cancer Treatment Product
Table 95. Novartis AG Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 96. Novartis AG Recent Development
Table 97. Ipsen Biopharmaceuticals Inc. Company Details
Table 98. Ipsen Biopharmaceuticals Inc. Business Overview
Table 99. Ipsen Biopharmaceuticals Inc. Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 100. Ipsen Biopharmaceuticals Inc. Recent Development
Table 101. Thermo Fisher Scientific Company Details
Table 102. Thermo Fisher Scientific Business Overview
Table 103. Thermo Fisher Scientific Paranasal Sinus Cancer Treatment Product
Table 104. Thermo Fisher Scientific Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 105. Thermo Fisher Scientific Recent Development
Table 106. Abbott Company Details
Table 107. Abbott Business Overview
Table 108. Abbott Paranasal Sinus Cancer Treatment Product
Table 109. Abbott Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 110. Abbott Recent Development
Table 111. GE Healthcare Company Details
Table 112. GE Healthcare Business Overview
Table 113. GE Healthcare Paranasal Sinus Cancer Treatment Product
Table 114. GE Healthcare Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 115. GE Healthcare Recent Development
Table 116. Agilent Technologies Inc. Company Details
Table 117. Agilent Technologies Inc. Business Overview
Table 118. Agilent Technologies Inc. Paranasal Sinus Cancer Treatment Product
Table 119. Agilent Technologies Inc. Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 120. Agilent Technologies Inc. Recent Development
Table 121. AstraZeneca Company Details
Table 122. AstraZeneca Business Overview
Table 123. AstraZeneca Paranasal Sinus Cancer Treatment Product
Table 124. AstraZeneca Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 125. AstraZeneca Recent Development
Table 126. Boehringer Ingelheim Company Details
Table 127. Boehringer Ingelheim Business Overview
Table 128. Boehringer Ingelheim Paranasal Sinus Cancer Treatment Product
Table 129. Boehringer Ingelheim Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 130. Boehringer Ingelheim Recent Development
Table 131. Bayer Company Details
Table 132. Bayer Business Overview
Table 133. Bayer Paranasal Sinus Cancer Treatment Product
Table 134. Bayer Revenue in Paranasal Sinus Cancer Treatment Business (2016-2021) & (US$ Million)
Table 135. Bayer Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paranasal Sinus Cancer Treatment Market Share : 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Radiotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Global Paranasal Sinus Cancer Treatment Market Share : 2020 VS 2027
Figure 6. Hospital and Clinics Case Studies
Figure 7. Cancer Treatment and Research Center Case Studies
Figure 8. Research Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Paranasal Sinus Cancer Treatment Report Years Considered
Figure 11. Global Paranasal Sinus Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Paranasal Sinus Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Paranasal Sinus Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Paranasal Sinus Cancer Treatment Market Share by Regions (2022-2027)
Figure 15. Global Paranasal Sinus Cancer Treatment Market Share by Players in 2020
Figure 16. Global Top Paranasal Sinus Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paranasal Sinus Cancer Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Paranasal Sinus Cancer Treatment Revenue in 2020
Figure 18. Global Paranasal Sinus Cancer Treatment Revenue Market Share (2016-2021)
Figure 19. Global Paranasal Sinus Cancer Treatment Revenue Market Share (2022-2027)
Figure 20. North America Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Paranasal Sinus Cancer Treatment Market Share (2016-2027)
Figure 22. North America Paranasal Sinus Cancer Treatment Market Share (2016-2027)
Figure 23. North America Paranasal Sinus Cancer Treatment Market Share by Country (2016-2027)
Figure 24. United States Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Paranasal Sinus Cancer Treatment Market Share (2016-2027)
Figure 28. Europe Paranasal Sinus Cancer Treatment Market Share (2016-2027)
Figure 29. Europe Paranasal Sinus Cancer Treatment Market Share by Country (2016-2027)
Figure 30. Germany Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Paranasal Sinus Cancer Treatment Market Share (2016-2027)
Figure 38. Asia-Pacific Paranasal Sinus Cancer Treatment Market Share (2016-2027)
Figure 39. Asia-Pacific Paranasal Sinus Cancer Treatment Market Share by Region (2016-2027)
Figure 40. China Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Paranasal Sinus Cancer Treatment Market Share (2016-2027)
Figure 48. Latin America Paranasal Sinus Cancer Treatment Market Share (2016-2027)
Figure 49. Latin America Paranasal Sinus Cancer Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Paranasal Sinus Cancer Treatment Market Share (2016-2027)
Figure 54. Middle East & Africa Paranasal Sinus Cancer Treatment Market Share (2016-2027)
Figure 55. Middle East & Africa Paranasal Sinus Cancer Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Paranasal Sinus Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie, Inc. Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 60. Pfizer Inc. Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 62. Bristol-Myers Squibb Company Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 64. Becton Dickinson Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 65. Novartis AG Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 66. Ipsen Biopharmaceuticals Inc. Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 68. Abbott Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 69. GE Healthcare Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 70. Agilent Technologies Inc. Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 71. AstraZeneca Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 72. Boehringer Ingelheim Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 73. Bayer Revenue Growth Rate in Paranasal Sinus Cancer Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年） Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC. Market Analysis and Insights: Global Cast…- 世界の洞不全症候群治療市場規模・現状・予測（2021年-2027年） Sick Sinus Syndrome is a group disorder including three heart rhythm problems (arrhythmias): sinus bradycardia (a slow heart rate), tachycardias (fast heart rates), and bradycardia-tachycardia (alternating slow and fast heart rhythms). Atrial fibrillation, atrial flutter/tachycardia, and supraventri…
- 世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年） Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Market Analysis and Insights: Global Anaplastic Thyroid Cancer Treatment Market The global Anaplastic T…
- 世界の転移性結腸直腸癌治療市場規模・現状・予測（2021年-2027年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- 世界の転移性乳がん治療市場規模・現状・予測（2021年-2027年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…